Drug Discovery News
-
Eisai and Biogen Japan collaborate to lead dementia genomics R&D with NCNP in Japan
Drug Discovery | News | 0 Comment | 26 Nov, 2024
Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...Read more
-
Hong Kong-based Insilico Medicine enters into revolving loan facility of up to $100 M with HSBC
Drug Discovery | News | 0 Comment | 05 Nov, 2024
Hong Kong-based Insilico Medicine, a global leading generative artificial intelligence (AI)-driven biotechnology company...Read more
-
Biomedical engineers in Australia design high-speed 3D bioprinter as gamechanger for drug discovery
Drug Discovery | News | 1 Comment | 04 Nov, 2024
Biomedical engineers from the University of Melbourne, Australia have invented a 3D printing system, or bioprinter, capa...Read more
-
Hong Kong Innovation Center opens to provide one-stop support for early-stage drug discovery
Drug Discovery | News | 1 Comment | 30 Oct, 2024
ATLATL Hong Kong Innovation Center, a new state-of-the-art research facility designed to provide immediate, move-in-read...Read more
-
Japan's Ono Pharma inks $700 M ADC deal with Korean firm LigaChem Biosciences
Drug Discovery | News | 0 Comment | 14 Oct, 2024
Japan-based Ono Pharmaceutical Co. has entered into a license agreement with LigaChem Biosciences, Inc., in South Korea,...Read more
-
Japanese startup Alpha Fusion accelerates astatine-based drug discovery with Series B funding
Drug Discovery | News | 0 Comment | 13 Oct, 2024
Alpha Fusion, Inc., working on research outcomes from Osaka University and the Japan Science and Technolo...Read more
-
World Companion Diagnostics and Liquid Biopsy Summit APAC to Unite 100+ Precision Medicine Experts
Drug Discovery | News | 0 Comment | 10 Oct, 2024
This exciting forum will gather the field to discuss the latest advancements in NGS, biomarker development, clinical tri...Read more
-
Eli Lilly invests $4.5 B to create Lilly Medicine Foundry for drug development
Drug Discovery | News | 0 Comment | 04 Oct, 2024
American pharmaceutical firm Eli Lilly and Company has announced a $4.5 billion investment to create the Lilly...Read more
-
BIOCHINA 2025: China’s Largest Bio Convention to Host Over 3,000 Biotech Companies
Drug Discovery | News | 0 Comment | 12 Sep, 2024
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...Read more
-
Drug Discovery | News | 0 Comment | 24 Aug, 2024
Bridge Biotherapeutics, a startup based in the Republic of Korea and the US, has entered into a joint research agreement...Read more
-
Innovations in Pharmaceutical Drug Delivery Systems
Drug Discovery | News | 0 Comment | 13 Jul, 2024
Advancements in Drug Delivery Technologies Innovative drug delivery systems have emerged to address the limitations of ...Read more
-
Australia invests $2 M to establish Queensland Drug Discovery Alliance
Drug Discovery | News | 0 Comment | 01 Aug, 2024
A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland&rsq...Read more
-
AstraZeneca partners with Japanese startup United Immunity for drug delivery tech research
Drug Discovery | News | 0 Comment | 30 Jul, 2024
AstraZeneca K.K. and United Immunity have signed an agreement for joint research on next-generation lipid nanoparticles ...Read more
-
Scientists in Australia invent new AI tool for rapid and cost-effective drug discovery
Drug Discovery | News | 0 Comment | 19 Jun, 2024
Australian researchers, led by Monash University, have invented a new artificial intelligence (AI) tool which is poised ...Read more
-
AbbVie inks deal worth $1.56 B with China's FutureGen to develop IBD therapy
Drug Discovery | News | 0 Comment | 17 Jun, 2024
US-based firm AbbVie and FutureGen Biopharmaceutical (Beijing) have announced a license agreement to develop FG-M701, a ...Read more
-
Oncocross expands collaboration with JW Pharma for AI-based oncology drug discovery in Korea
Drug Discovery | News | 0 Comment | 27 May, 2024
Oncocross, a Seoul-based artificial intelligence (AI) drug discovery and development biotech startup, has signed a joint...Read more
-
Japan's Shionogi announces $150 M deal to develop first oral therapy for Pompe Disease
Drug Discovery | News | 0 Comment | 13 May, 2024
Japan-based Shionogi & Co. and Maze Therapeutics, Inc., in the US, have completed an exclusive worldwide license agr...Read more
-
Drug Discovery | News | 0 Comment | 08 May, 2024
A team of scientists from A*STAR’s Genome Institute of Singapore (GIS) and Bioinformatics Institute (BII) has deve...Read more
